Host Interactions of HIV factors (Homo sapiens)
From WikiPathways
Description
Like all viruses, HIV-1 must co-opt the host cell macromolecular transport and processing machinery. HIV-1 Vpr and Rev proteins play key roles in this co-optation. Efficient HIV-1 replication likewise requires evasion of APOBEC3G-mediated mutagenesis of reverse transcripts, a process mediated by the viral Vif protein.
View original pathway at:Reactome.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Kabachinski G, Schwartz TU.; ''The nuclear pore complex--structure and function at a glance.''; PubMed Europe PMC Scholia
- Margottin F, Bour SP, Durand H, Selig L, Benichou S, Richard V, Thomas D, Strebel K, Benarous R.; ''A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.''; PubMed Europe PMC Scholia
- Vodicka MA, Koepp DM, Silver PA, Emerman M.; ''HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection.''; PubMed Europe PMC Scholia
- Saksela K, Cheng G, Baltimore D.; ''Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4.''; PubMed Europe PMC Scholia
- Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L.; ''The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.''; PubMed Europe PMC Scholia
- Meyer BE, Malim MH.; ''The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm.''; PubMed Europe PMC Scholia
- Arold S, Franken P, Strub MP, Hoh F, Benichou S, Benarous R, Dumas C.; ''The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.''; PubMed Europe PMC Scholia
- Askjaer P, Jensen TH, Nilsson J, Englmeier L, Kjems J.; ''The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP.''; PubMed Europe PMC Scholia
- Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF.; ''Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.''; PubMed Europe PMC Scholia
- Rabut G, Doye V, Ellenberg J.; ''Mapping the dynamic organization of the nuclear pore complex inside single living cells.''; PubMed Europe PMC Scholia
- Mahboobi SH, Javanpour AA, Mofrad MR.; ''The interaction of RNA helicase DDX3 with HIV-1 Rev-CRM1-RanGTP complex during the HIV replication cycle.''; PubMed Europe PMC Scholia
- Zapp ML, Green MR.; ''Sequence-specific RNA binding by the HIV-1 Rev protein.''; PubMed Europe PMC Scholia
- Bischoff FR, Krebber H, Kempf T, Hermes I, Ponstingl H.; ''Human RanGTPase-activating protein RanGAP1 is a homologue of yeast Rna1p involved in mRNA processing and transport.''; PubMed Europe PMC Scholia
- Roeth JF, Williams M, Kasper MR, Filzen TM, Collins KL.; ''HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail.''; PubMed Europe PMC Scholia
- Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ.; ''Proteomic analysis of the mammalian nuclear pore complex.''; PubMed Europe PMC Scholia
- Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J, Miller WT.; ''Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.''; PubMed Europe PMC Scholia
- Janardhan A, Swigut T, Hill B, Myers MP, Skowronski J.; ''HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis.''; PubMed Europe PMC Scholia
- Marin M, Rose KM, Kozak SL, Kabat D.; ''HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.''; PubMed Europe PMC Scholia
- Li K, Warner CK, Hodge JA, Minoshima S, Kudoh J, Fukuyama R, Maekawa M, Shimizu Y, Shimizu N, Wallace DC.; ''A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed.''; PubMed Europe PMC Scholia
- Kamata M, Nitahara-Kasahara Y, Miyamoto Y, Yoneda Y, Aida Y.; ''Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr.''; PubMed Europe PMC Scholia
- Ori A, Banterle N, Iskar M, Iskar M, Andrés-Pons A, Escher C, Khanh Bui H, Sparks L, Solis-Mezarino V, Rinner O, Bork P, Lemke EA, Beck M.; ''Cell type-specific nuclear pores: a case in point for context-dependent stoichiometry of molecular machines.''; PubMed Europe PMC Scholia
- Kobayashi M, Takaori-Kondo A, Miyauchi Y, Iwai K, Uchiyama T.; ''Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function.''; PubMed Europe PMC Scholia
- Popov S, Rexach M, Ratner L, Blobel G, Bukrinsky M.; ''Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex.''; PubMed Europe PMC Scholia
- Garcia JV, Miller AD.; ''Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.''; PubMed Europe PMC Scholia
- Le Rouzic E, Mousnier A, Rustum C, Stutz F, Hallberg E, Dargemont C, Benichou S.; ''Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1.''; PubMed Europe PMC Scholia
- Renkema GH, Manninen A, Mann DA, Harris M, Saksela K.; ''Identification of the Nef-associated kinase as p21-activated kinase 2.''; PubMed Europe PMC Scholia
- Wei P, Garber ME, Fang SM, Fischer WH, Jones KA.; ''A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.''; PubMed Europe PMC Scholia
- Daugherty MD, Liu B, Frankel AD.; ''Structural basis for cooperative RNA binding and export complex assembly by HIV Rev.''; PubMed Europe PMC Scholia
- Wei SJ, Williams JG, Dang H, Darden TA, Betz BL, Humble MM, Chang FM, Trempus CS, Johnson K, Cannon RE, Tennant RW.; ''Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation.''; PubMed Europe PMC Scholia
- Fritz CC, Green MR.; ''HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAs.''; PubMed Europe PMC Scholia
- Renkema GH, Manninen A, Saksela K.; ''Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX.''; PubMed Europe PMC Scholia
- Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Briand JP, Irinopoulou T, Daugas E, Susin SA, Cointe D, Xie ZH, Reed JC, Roques BP, Kroemer G.; ''The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore.''; PubMed Europe PMC Scholia
- Lin DH, Stuwe T, Schilbach S, Rundlet EJ, Perriches T, Mobbs G, Fan Y, Thierbach K, Huber FM, Collins LN, Davenport AM, Jeon YE, Hoelz A.; ''Architecture of the symmetric core of the nuclear pore.''; PubMed Europe PMC Scholia
- Arora VK, Molina RP, Foster JL, Blakemore JL, Chernoff J, Fredericksen BL, Garcia JV.; ''Lentivirus Nef specifically activates Pak2.''; PubMed Europe PMC Scholia
- Yang X, Gold MO, Tang DN, Lewis DE, Aguilar-Cordova E, Rice AP, Herrmann CH.; ''TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines.''; PubMed Europe PMC Scholia
- Grzesiek S, Bax A, Clore GM, Gronenborn AM, Hu JS, Kaufman J, Palmer I, Stahl SJ, Wingfield PT.; ''The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase.''; PubMed Europe PMC Scholia
- Wang JK, Kiyokawa E, Verdin E, Trono D.; ''The Nef protein of HIV-1 associates with rafts and primes T cells for activation.''; PubMed Europe PMC Scholia
- Raney A, Kuo LS, Baugh LL, Foster JL, Garcia JV.; ''Reconstitution and molecular analysis of an active human immunodeficiency virus type 1 Nef/p21-activated kinase 2 complex.''; PubMed Europe PMC Scholia
- Sheehy AM, Gaddis NC, Malim MH.; ''The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.''; PubMed Europe PMC Scholia
- Henderson BR, Percipalle P.; ''Interactions between HIV Rev and nuclear import and export factors: the Rev nuclear localisation signal mediates specific binding to human importin-beta.''; PubMed Europe PMC Scholia
- Wei BL, Arora VK, Raney A, Kuo LS, Xiao GH, O'Neill E, Testa JR, Foster JL, Garcia JV.; ''Activation of p21-activated kinase 2 by human immunodeficiency virus type 1 Nef induces merlin phosphorylation.''; PubMed Europe PMC Scholia
- Voges D, Zwickl P, Baumeister W.; ''The 26S proteasome: a molecular machine designed for controlled proteolysis.''; PubMed Europe PMC Scholia
- Bischoff FR, Ponstingl H.; ''Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1.''; PubMed Europe PMC Scholia
- Szebeni A, Mehrotra B, Baumann A, Adam SA, Wingfield PT, Olson MO.; ''Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin.''; PubMed Europe PMC Scholia
- Herrmann CH, Rice AP.; ''Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor.''; PubMed Europe PMC Scholia
- Malim MH, Tiley LS, McCarn DF, Rusche JR, Hauber J, Cullen BR.; ''HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.''; PubMed Europe PMC Scholia
- Yi R, Bogerd HP, Cullen BR.; ''Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs.''; PubMed Europe PMC Scholia
- Fankhauser C, Izaurralde E, Adachi Y, Wingfield P, Laemmli UK.; ''Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element.''; PubMed Europe PMC Scholia
- Malim MH, Cullen BR.; ''HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency.''; PubMed Europe PMC Scholia
- Fauré J, Stalder R, Borel C, Sobo K, Piguet V, Demaurex N, Gruenberg J, Trono D.; ''ARF1 regulates Nef-induced CD4 degradation.''; PubMed Europe PMC Scholia
- Swigut T, Shohdy N, Skowronski J.; ''Mechanism for down-regulation of CD28 by Nef.''; PubMed Europe PMC Scholia
- Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR.; ''Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.''; PubMed Europe PMC Scholia
- Stove V, Van de Walle I, Naessens E, Coene E, Stove C, Plum J, Verhasselt B.; ''Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta.''; PubMed Europe PMC Scholia
- Suntharalingam M, Wente SR.; ''Peering through the pore: nuclear pore complex structure, assembly, and function.''; PubMed Europe PMC Scholia
- De Marcos Lousa C, Trézéguet V, Dianoux AC, Brandolin G, Lauquin GJ.; ''The human mitochondrial ADP/ATP carriers: kinetic properties and biogenesis of wild-type and mutant proteins in the yeast S. cerevisiae.''; PubMed Europe PMC Scholia
- Cheng H, Hoxie JP, Parks WP.; ''The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes.''; PubMed Europe PMC Scholia
- Fontoura BM, Blobel G, Matunis MJ.; ''A conserved biogenesis pathway for nucleoporins: proteolytic processing of a 186-kilodalton precursor generates Nup98 and the novel nucleoporin, Nup96.''; PubMed Europe PMC Scholia
- Kosinski J, Mosalaganti S, von Appen A, Teimer R, DiGuilio AL, Wan W, Bui KH, Hagen WJ, Briggs JA, Glavy JS, Hurt E, Beck M.; ''Molecular architecture of the inner ring scaffold of the human nuclear pore complex.''; PubMed Europe PMC Scholia
- Zennou V, Perez-Caballero D, Göttlinger H, Bieniasz PD.; ''APOBEC3G incorporation into human immunodeficiency virus type 1 particles.''; PubMed Europe PMC Scholia
- Agopian K, Wei BL, Garcia JV, Gabuzda D.; ''CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.''; PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Annotated Interactions
View all... |
Source | Target | Type | Database reference | Comment |
---|---|---|---|---|
26S proteasome | mim-catalysis | R-HSA-180573 (Reactome) | ||
26S proteasome | mim-catalysis | R-HSA-180603 (Reactome) | ||
ADP/ATP translocase monomer (generic) | R-HSA-180905 (Reactome) | |||
ANT1:Vpr complex | Arrow | R-HSA-180905 (Reactome) | ||
AP-1 Complex | Arrow | R-HSA-182263 (Reactome) | ||
AP-1 Complex | R-HSA-182279 (Reactome) | |||
AP-2 Complex | Arrow | R-HSA-167601 (Reactome) | ||
AP-2 Complex | Arrow | R-HSA-182171 (Reactome) | ||
AP-2 Complex | R-HSA-167537 (Reactome) | |||
AP-2 Complex | R-HSA-182186 (Reactome) | |||
AP2M1 | R-HSA-167633 (Reactome) | |||
APOBEC3G:HIV-1PIC | Arrow | R-HSA-180630 (Reactome) | ||
APOBEC3G:RTC with
deaminated minus sssDNA:tRNA primer:RNA template | Arrow | R-HSA-180632 (Reactome) | ||
APOBEC3G:RTC with
minus sssDNA:tRNA primer:RNA template | Arrow | R-HSA-180634 (Reactome) | ||
APOBEC3G:RTC with
minus sssDNA:tRNA primer:RNA template | R-HSA-180632 (Reactome) | |||
APOBEC3G:Vif:Cul5:SCF complex | Arrow | R-HSA-180555 (Reactome) | ||
APOBEC3G:Vif:Cul5:SCF complex | R-HSA-180540 (Reactome) | |||
APOBEC3G:Vif:Cul5:SCF complex | mim-catalysis | R-HSA-180540 (Reactome) | ||
APOBEC3G | R-HSA-180602 (Reactome) | |||
APOBEC3G | R-HSA-180630 (Reactome) | |||
APOBEC3G | R-HSA-180634 (Reactome) | |||
APOBEC3G | mim-catalysis | R-HSA-180632 (Reactome) | ||
ARF1 | R-HSA-200879 (Reactome) | |||
ATP6V1H | Arrow | R-HSA-167601 (Reactome) | ||
ATP6V1H | Arrow | R-HSA-182171 (Reactome) | ||
ATP6V1H | R-HSA-167537 (Reactome) | |||
ATP6V1H | R-HSA-182186 (Reactome) | |||
Arf1:Nef:endosomal CD4 | Arrow | R-HSA-200879 (Reactome) | ||
BTRC | R-HSA-180591 (Reactome) | |||
CCNT1 | R-HSA-167235 (Reactome) | |||
CD247-1 | R-HSA-164943 (Reactome) | |||
CD28:Nef:Clathrin-coated Pit Adapter Protein Complex | Arrow | R-HSA-167633 (Reactome) | ||
CD28:Nef:Clathrin-coated Pit Adapter Protein Complex | R-HSA-167637 (Reactome) | |||
CD28:Nef:Clathrin-coated Pit Adapter Protein | Arrow | R-HSA-167637 (Reactome) | ||
CD28 | R-HSA-167630 (Reactome) | |||
CD4:Lck Complex | R-HSA-167566 (Reactome) | |||
CD4:Nef Complex | Arrow | R-HSA-167566 (Reactome) | ||
CD4:Nef Complex | R-HSA-167537 (Reactome) | |||
CD4:Nef:AP-2
Complex:v-ATPase Complex | Arrow | R-HSA-167537 (Reactome) | ||
CD4:Nef:AP-2
Complex:v-ATPase Complex | R-HSA-167597 (Reactome) | |||
CD4:Vpu complex | Arrow | R-HSA-180606 (Reactome) | ||
CD4:Vpu complex | R-HSA-180591 (Reactome) | |||
CD4:Vpu:beta-TrCP_1:Skp1 complex | Arrow | R-HSA-180599 (Reactome) | ||
CD4:Vpu:beta-TrCP_1:Skp1 complex | R-HSA-180597 (Reactome) | |||
CD4:Vpu:beta-TrCP_1:Skp1 complex | mim-catalysis | R-HSA-180597 (Reactome) | ||
CD4:Vpu:beta-TrCP_1 | Arrow | R-HSA-180591 (Reactome) | ||
CD4:Vpu:beta-TrCP_1 | R-HSA-180599 (Reactome) | |||
CD4 | R-HSA-180606 (Reactome) | |||
CD4 | R-HSA-200879 (Reactome) | |||
CD8:Nef Complex | R-HSA-182186 (Reactome) | |||
CD8:Nef:AP-2
Complex:v-ATPase Complex | Arrow | R-HSA-182186 (Reactome) | ||
CD8:Nef:AP-2
Complex:v-ATPase Complex | R-HSA-182198 (Reactome) | |||
CDK9 | R-HSA-167235 (Reactome) | |||
Cul5-SCF complex | R-HSA-180555 (Reactome) | |||
DOCK2:ELMO1:RAC1:Nef Complex | Arrow | R-HSA-200952 (Reactome) | ||
DOCK2 | R-HSA-200952 (Reactome) | |||
ELMO1 | R-HSA-200952 (Reactome) | |||
FYN | R-HSA-200908 (Reactome) | |||
Fyn:Nef Complex | Arrow | R-HSA-200908 (Reactome) | ||
GDP | Arrow | R-HSA-180687 (Reactome) | ||
GTP | R-HSA-180687 (Reactome) | |||
H2O | R-HSA-180632 (Reactome) | |||
HCK | R-HSA-200858 (Reactome) | |||
HIV-1 mRNA | R-HSA-165027 (Reactome) | |||
HIV-1 unspliced RNA | Arrow | R-HSA-165028 (Reactome) | ||
Hck-1:Nef | Arrow | R-HSA-200858 (Reactome) | ||
IN bound to sticky
3' ends of viral DNA in PIC | R-HSA-180622 (Reactome) | |||
IN bound to sticky
3' ends of viral DNA in PIC | R-HSA-180627 (Reactome) | |||
IN bound to sticky
3' ends of viral DNA in PIC | R-HSA-180630 (Reactome) | |||
Importin beta-1:Rev multimer complex | Arrow | R-HSA-180709 (Reactome) | ||
Importin beta-1:Rev multimer complex | R-HSA-180725 (Reactome) | |||
Importin-beta:Ran GTP complex | Arrow | R-HSA-180736 (Reactome) | ||
Internalized CD4:Nef:Clathrin-Coated Pit Adapter Protein:v-ATPase | Arrow | R-HSA-167597 (Reactome) | ||
Internalized CD4:Nef:Clathrin-Coated Pit Adapter Protein:v-ATPase | R-HSA-167601 (Reactome) | |||
Internalized CD8:Nef:Clathrin-Coated Pit Adapter Protein:v-ATPase | Arrow | R-HSA-182198 (Reactome) | ||
Internalized CD8:Nef:Clathrin-Coated Pit Adapter Protein:v-ATPase | R-HSA-182171 (Reactome) | |||
KPNA1 | R-HSA-180627 (Reactome) | |||
KPNB1 | R-HSA-180709 (Reactome) | |||
LCK | Arrow | R-HSA-167566 (Reactome) | ||
LCK | R-HSA-200954 (Reactome) | |||
Lck:Nef | Arrow | R-HSA-200954 (Reactome) | ||
Lipid Raft | R-HSA-164943 (Reactome) | |||
NH3 | Arrow | R-HSA-180632 (Reactome) | ||
NPM1 | Arrow | R-HSA-180736 (Reactome) | ||
NPM1 | R-HSA-180725 (Reactome) | |||
Nef:CD28 Complex | Arrow | R-HSA-167630 (Reactome) | ||
Nef:CD28 Complex | R-HSA-167633 (Reactome) | |||
Nef:T cell Receptor
zeta:Lipid Raft: Pak 2 Complex | Arrow | R-HSA-164943 (Reactome) | ||
Nef:class I MHC
complex:AP-1:PACS-1 Complex | Arrow | R-HSA-182286 (Reactome) | ||
Nef:class I MHC
complex:AP-1:PACS-1 Complex | R-HSA-182263 (Reactome) | |||
Nef:class I MHC
complex:Ap-1:PACS-1 Complex | Arrow | R-HSA-182279 (Reactome) | ||
Nef:class I MHC
complex:Ap-1:PACS-1 Complex | R-HSA-182286 (Reactome) | |||
Nef:class I MHC complex | Arrow | R-HSA-182243 (Reactome) | ||
Nef:class I MHC complex | R-HSA-182279 (Reactome) | |||
Nuclear Pore Complex (NPC) | Arrow | R-HSA-165047 (Reactome) | ||
Nuclear Pore Complex (NPC) | Arrow | R-HSA-180732 (Reactome) | ||
Nuclear Pore Complex (NPC) | R-HSA-165043 (Reactome) | |||
Nuclear Pore Complex (NPC) | R-HSA-180622 (Reactome) | |||
Nuclear Pore Complex (NPC) | R-HSA-180710 (Reactome) | |||
P-TEFb(Cyclin T1:Cdk9) complex | Arrow | R-HSA-167235 (Reactome) | ||
P-TEFb(Cyclin T1:Cdk9) complex | R-HSA-167234 (Reactome) | |||
PACS1 | Arrow | R-HSA-182263 (Reactome) | ||
PACS1 | R-HSA-182279 (Reactome) | |||
PAK2(1-524) | R-HSA-164943 (Reactome) | |||
PIC anchored to the NPC | Arrow | R-HSA-180622 (Reactome) | ||
Pi | Arrow | R-HSA-165055 (Reactome) | ||
R-HSA-164943 (Reactome) | Nef drives the formation of lipid raft complexes. | |||
R-HSA-165027 (Reactome) | Nuclear export of the unspliced and partially spliced HIV-1 transcripts requires the association of the HIV-1 Rev protein with a cis-acting RNA sequence known as the Rev Response Element (RRE) located within the env gene. The RRE forms a stem loop structure that associates with an arginine-rich RNA binding motif (ARM) within Rev. | |||
R-HSA-165028 (Reactome) | The association of RanBp1 with RanGTP:CRM1:Rev promotes disassembly of the complex and release of the Rev:RNA cargo (Mahboobi et al. 2015). | |||
R-HSA-165033 (Reactome) | In order for Rev to function, multiple molecules must bind sequentiallly to the RRE (Malim and Cullen 1991). | |||
R-HSA-165034 (Reactome) | RanGTP binds to a preformed Rev-CRM1 complex. | |||
R-HSA-165043 (Reactome) | The Rev multimer-bound HIV-1 mRNA:Crm1:Ran:GTP complex associates with the NPC (Askjaer et al. 1998; Daugherty et al. 2010). | |||
R-HSA-165047 (Reactome) | Crm1 is a nucleocytoplasmic transport factor that is believed to interact with nucleoporins facilitating docking of the RRE-Rev-CRM1-RanGTP complex to the nuclear pore and the translocation of the complex across the nuclear pore complex (see Cullen 1998) Crm1 has been found in complex with two such nucleoporins, CAN/Nup214 and Nup88 which have been shown to be components of the human nuclear pore complex (Fornerod et al., 1997). | |||
R-HSA-165055 (Reactome) | Ran-GAP, a Ran-specific GTPase-activating protein converts Ran-GTP to Ran-GDP, producing a Ran-GTP gradient across the nuclear membrane. | |||
R-HSA-167234 (Reactome) | Tat associates with the Cyclin T1 subunit of P-TEFb (Cyclin T1:Cdk9) through a region of cysteine-rich and core sequences referred to as the ARM domain within Tat (Wei et al., 1998; see also Herrmann 1995). This interaction is believed to involve metal ions stabilized by cysteine residues in both proteins (Bieniasz et al., 1998; Garber et al., 1998). | |||
R-HSA-167235 (Reactome) | Tat associates with the Cyclin T1 subunit of the cellular kinase complex TAK/P-TEFb and recruits this complex to the TAR sequence in the HIV-1 RNA (Wei et al. 1998). This association between TAT, TAR and TAK/P-TEFb is believed to bring the catalytic subunit of TAK/P-TEFb in close proximity to Pol II where it hyperphosphorylates the CTD of Pol II . | |||
R-HSA-167537 (Reactome) | AP-2 is recruited to the newly formed Nef:CD4 complex | |||
R-HSA-167566 (Reactome) | Nef disrupts the CD4 Lck complex | |||
R-HSA-167597 (Reactome) | The Nef:CD4:AP-2 complex is internalized | |||
R-HSA-167601 (Reactome) | CD4 is degraded | |||
R-HSA-167630 (Reactome) | Down-regulation of CD28 receptors involves a dileucine-based motif in the second disordered loop of Nef, which connects Nef to adaptor protein (AP) complex, which is a part of cellular endocytosis machinery. | |||
R-HSA-167633 (Reactome) | Nef induces accelerated endocytosis of CD28 via clathrin-coated pits. | |||
R-HSA-167637 (Reactome) | Once Nef has induced endocytosis of CD28, CD28 containing vesicles are targeted for lysosomal degradation. | |||
R-HSA-180540 (Reactome) | APOBEC3G is multi-ubiquitinated by the Vif-Cul5-SCF complex. | |||
R-HSA-180555 (Reactome) | The interaction between Vif and the E3 ubiquitin ligase complex (Cullin5, Elongin B and Elongin C, and Rbx1) takes place through direct binding of the SOCS box motif in the viral protein Vif to the host protein Elongin C. Moreover, a conserved HCCH motif in Vif allows binding to Cullin 5. | |||
R-HSA-180573 (Reactome) | Ubiquitinated CD4 is then subject to proteasome-mediated degradation. | |||
R-HSA-180591 (Reactome) | Vpu links beta-TrCP to CD4 at the ER membrane through interactions with beta-TrCP and the cytoplasmic tail of CD4. | |||
R-HSA-180597 (Reactome) | CD4 is ubiquitinated in the CD4:Vpu–h-βTrCP:Skp1 complex. | |||
R-HSA-180599 (Reactome) | The SKP1 component of the SCF complex is recruited to the Vpu:beta-TrCP:CD4 complex. | |||
R-HSA-180602 (Reactome) | The HIV-1 Vif protein associates with the DNA editing enzyme APOBEC3G Marin et al) . The binding site has not yet been mapped but emerging evidence suggest that the N-terminal lregion of Vif is essential for APOBEC3G recognition (Tian et al) . Substitution of a single amino acid in the human APOBEC3G (Asp128Lys) abolishes binding and renders it resistant to HIV-1 Vif (Schrofelbauer et al; Bogerd et al.). | |||
R-HSA-180603 (Reactome) | Following multi-ubiquitination by the Vif-Cul5-SCF complex, APOBEC3G is degraded by the 26S proteasome. | |||
R-HSA-180606 (Reactome) | Vpu is expressed in the ER and associates with a membrane-proximal region in the cytoplasmic tail of CD4. | |||
R-HSA-180622 (Reactome) | Vpr binds to nucleoporins. | |||
R-HSA-180627 (Reactome) | Vpr interacts with importin-alpha through alphaH1 and alphaH2. The interaction via alphaH1 is indispensable for the nuclear entry of Vpr (Kamata et al., 2005) . | |||
R-HSA-180630 (Reactome) | APOBEC3G is incorporated into virus particles through its association with components of the viral RNA packaging machinery. It binds to the nucleocapsid portion of Gag (NC), a region of the polyprotein that associates with genomic RNA and functions in RNA encapsidation. | |||
R-HSA-180632 (Reactome) | During reverse transcription, APOBEC3G-mediated minus-strand deamination occurs within a CC dinucleotide context over the entire length of the HIV-1 genome (Yu et al., 2004). The polypurine tract is essential for plus strand synthesis and is located at the 3' end of the retroviral genome. HIV-1 encodes an additional central polypurine tract located in the middle of the genome which also serves as primer for plus strand synthesis. Deamination of the minus strand continues throughout its synthesis with the frequency of deamination events increasing from the 5' to 3' regions. A 400bp region downstream of the central polypurine tract seems to be protected from deamination (Wurtzer et al., 2006) | |||
R-HSA-180634 (Reactome) | In the target cell, HIV-1-associated APOBEC3G binds to the HIV-1 reverse transcript minus strand and catalyzes the deamination of cytidines in a specific dinucleotide context (e.g., dCC). In contrast, APOBEC3F and APOBEC3B display a preference for dTC. | |||
R-HSA-180687 (Reactome) | Free, nuclear RanGTP is required for export processes out of the nucleus. RCC1 catalyses the conversion of Ran-GDP to Ran-GTP in the nucleus. | |||
R-HSA-180709 (Reactome) | The association of Rev with importin-beta is mediated by the Rev nuclear localisation signal. | |||
R-HSA-180710 (Reactome) | The Rev-importin beta-B23 complex is recruited to the nuclear pore by an interaction between importin beta and nucleoporin. | |||
R-HSA-180725 (Reactome) | B23 may function as a shuttle for the import of HIV Rev from the cytoplasm into the nucleus or nucleolus permitting additional rounds of export of viral RNAs. | |||
R-HSA-180728 (Reactome) | Inside the nucleus, Ran-GTP associates with importin-beta. | |||
R-HSA-180732 (Reactome) | Following the association of Rev with importin-beta, the Rev:B23:importin-beta complex is imported into the nucleus. | |||
R-HSA-180736 (Reactome) | The association of importin-beta with Ran-GTP causes the disassembly of the Rev-importin β-B23 complex releasing the Rev in the nucleus. | |||
R-HSA-180739 (Reactome) | Upon translocation to the cytoplasm, RanBP1 associates with Ran-GTP in the Rev-CRM1-Ran-GTP complex. | |||
R-HSA-180855 (Reactome) | Vpr translocates to the mitochondria. | |||
R-HSA-180885 (Reactome) | CRM1 associates directly with Rev through the Rev nuclear export signal (NES) domain and acts as the nuclear export receptor for the Rev-RRE ribonucleoprotein complex. | |||
R-HSA-180905 (Reactome) | Vpr interacts with the PTPC component ANT1. This interaction induces mitochondrial membrane permeabilization and release of cytochrome c and apoptotic factors. | |||
R-HSA-182171 (Reactome) | Once the CD8alphabeta receptor has been internalized via endocytosis, the vesicles are targeted for lysosomal degradation. | |||
R-HSA-182186 (Reactome) | The presence of Nef accelerates endocytosis and lysosomal degradation of the transmembrane glycoprotein CD8. Nef facilitates a cascade of protein interactions that ultimately result in the degradation of internalized CD8 protein. The final set of protein interactions that direct Nef to the beta-subunit of the COPI coatomers are at this time unclear. A number of sites within Nef are proposed to be required for CD8 down-regulation, the myristoylation signal and N-terminal anchor regions, the C-terminal flexible loop, and amino acid positions 57 to 58. Consistent with all reported Nef functions, the myristoylation signal was found to be essential for CD8 down-modulation. The flexible loop contains a dileucine-based internalization motif, which is flanked by acidic clusters and is involved in enhanced internalization of the Nef-CD4 complex. | |||
R-HSA-182198 (Reactome) | The CD8alphabeta receptor is internalized via endocytosis. | |||
R-HSA-182243 (Reactome) | Nef disrupts the transport of major histocompatibility complex class I molecules by first binding to the the cytoplasmic side of the transmembrane complex. | |||
R-HSA-182263 (Reactome) | Once the complex of Nef, major histocompatibility complex class I molecules, PACS-1 and AP-1 arrives at the endosome, the MHC I complex is targeted for degradation. | |||
R-HSA-182279 (Reactome) | The complex formed by Nef and the major histocompatibility complex class I molecules creates binding sites for PACS-1 and the AP-1 complex. | |||
R-HSA-182286 (Reactome) | The complex of Nef, major histocompatibility complex class I molecules, PACS-1 and AP-1 is transported from the trans-Golgi network to an endosome, where the MHC I complex will be degraded. | |||
R-HSA-200858 (Reactome) | The protein Hck is a member of the Src family of non-receptor tyrosine kinases which is preferentially expressed in haematopoietic cells of the myeloid and B-lymphoid lineages. Src kinases are inhibited by tyrosine-phosphorylation at a carboxy-terminal site. The SH2 domains of these enzymes play an essential role in this regulation by binding to the tyrosine-phosphorylated tail. The SH2 domain of Hck regulates enzymatic activity indirectly; intramolecular interactions between the SH3 and catalytic domains appear to stabilize an inactive form of the kinase. The HIV-1 Nef protein, which is a high-affinity ligand for the Hck SH3 domain, binds to either the downregulated or activated form of Hck causing a large increase in Hck catalytic activity. The intact SH3-binding motif in Nef is crucial for Hck activation. | |||
R-HSA-200879 (Reactome) | The HIV Nef protein downregulates CD4 through sequential connection with clathrin-coated pits and the COP1 coatomer, resulting in accelerated endocytosis and lysosomal targeting. The small GTPase ARF1 controls the Nef-induced, COP-mediated late-endosomal targeting of CD4. Nef binds ARF1 directly and can recruit the GTPase onto endosomal membranes, leading to the eventual degradation of CD4 (Faure et al. 2004). | |||
R-HSA-200908 (Reactome) | Nef has been shown to bind specifically to a subset of the Src family of kinases. Nef/Fyn interaction centers on a proline-rich motif (Pro-x-x-Pro), which is implicated in SH3 binding. This domain is partially disordered in the absence of the binding partner; when bound this motif fully adopts a left-handed polyproline type II helix conformation upon complex formation with the Fyn SH3 domain. Within this structure the arginine residue (Arg77) of Nef interacts with Asp 100 of the RT loop within the Fyn SH3 domain, and triggers a hydrogen-bond rearrangement which allows the loop to adapt to complement the Nef surface. The Arg96 residue of the Fyn SH3 domain is specifically accommodated in the same hydrophobic pocket of Nef. The Nef-Fyn complex forms in vivo and may have a crucial role in the T cell perturbating action of Nef by altering T cell receptor signaling. | |||
R-HSA-200952 (Reactome) | The infectious cycle of primate lentiviruses is intimately linked to interactions between cells of the immune system. Nef, a potent virulence factor, alters cellular environments to increase lentiviral replication in the host, functioning as an adaptor protein. Nef activates Rac in T cell lines and in primary T cells following infection with HIV-1 in the absence of antigenic stimuli. Nef activates Rac by binding the DOCK2-ELMO1 complex, and this interaction is linked to the abilities of Nef to inhibit chemotaxis and promote T cell activation. Nef targets a critical switch that regulates Rac GTPases downstream of chemokine- and antigen-initiated signaling pathways. This interaction enables Nef to influence multiple aspects of T cell function and thus provides an important mechanism by which Nef impacts pathogenesis by primate lentiviruses. | |||
R-HSA-200954 (Reactome) | The Nef protein of the primate lentiviruses, including human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV), is a myristylated protein associated with increased viral replication and enhanced pathogenicity. Both the potentiation of T-lymphocyte activation and the enhanced serine-phosphorylation of HIV-1 capsid by Nef correlate with increased viral replication. The Nef proteins from HIV-1 and SIV bind to Lck. The SH3 and SH2 domains of Lck are sufficient for coprecipitation with non-tyrosine-phosphorylated Nef proteins. The conserved core region of HIV-1 Nef is essential for the interaction with Lck and is also important for enhanced HIV-1 replication in T-lymphocytes. The SIV and HIV-1 Nef proteins are differentially tyrosine-phosphorylated. The kinase-active Lck tyrosine-phosphorylates SIVmac239 Nef but does not phosphorylate HIV-1 Nef. | |||
RAC1 | R-HSA-200952 (Reactome) | |||
RANBP1 | Arrow | R-HSA-165028 (Reactome) | ||
RANBP1 | Arrow | R-HSA-165055 (Reactome) | ||
RANBP1 | R-HSA-180739 (Reactome) | |||
RANGAP1 | Arrow | R-HSA-165055 (Reactome) | ||
RCC1 | mim-catalysis | R-HSA-180687 (Reactome) | ||
REV (P04618) protein | Arrow | R-HSA-165028 (Reactome) | ||
REV (P04618) protein | R-HSA-165027 (Reactome) | |||
RTC with minus
sssDNA:tRNA primer:RNA template | R-HSA-180634 (Reactome) | |||
Ran GTPase:GDP | Arrow | R-HSA-165055 (Reactome) | ||
Ran-GDP | R-HSA-180687 (Reactome) | |||
Ran-GTP | Arrow | R-HSA-180687 (Reactome) | ||
Ran-GTP | R-HSA-165034 (Reactome) | |||
Ran-GTP | R-HSA-180728 (Reactome) | |||
Ran:GTP | Arrow | R-HSA-165028 (Reactome) | ||
Ran:GTP | R-HSA-165055 (Reactome) | |||
RanBP1:Ran-GTP:CRM1:Rev-bound mRNA complex | Arrow | R-HSA-180739 (Reactome) | ||
RanBP1:Ran-GTP:CRM1:Rev-bound mRNA complex | R-HSA-165028 (Reactome) | |||
Rev
multimer-bound HIV-1 mRNA:Crm1:Ran:GTP:NPC | Arrow | R-HSA-165043 (Reactome) | ||
Rev
multimer-bound HIV-1 mRNA:Crm1:Ran:GTP:NPC | R-HSA-165047 (Reactome) | |||
Rev multimer-bound
HIV-1 mRNA:Crm1:Ran:GTP | Arrow | R-HSA-165034 (Reactome) | ||
Rev multimer-bound
HIV-1 mRNA:Crm1:Ran:GTP | Arrow | R-HSA-165047 (Reactome) | ||
Rev multimer-bound
HIV-1 mRNA:Crm1:Ran:GTP | R-HSA-165043 (Reactome) | |||
Rev multimer-bound
HIV-1 mRNA:Crm1:Ran:GTP | R-HSA-180739 (Reactome) | |||
Rev multimer-bound
HIV-1 mRNA:Crm1:Ran:GTP | mim-catalysis | R-HSA-165055 (Reactome) | ||
Rev multimer-bound
HIV-1 mRNA:CRM1 complex | Arrow | R-HSA-180885 (Reactome) | ||
Rev multimer-bound
HIV-1 mRNA:CRM1 complex | R-HSA-165034 (Reactome) | |||
Rev multimer-bound HIV-1 mRNA | Arrow | R-HSA-165033 (Reactome) | ||
Rev multimer-bound HIV-1 mRNA | R-HSA-180885 (Reactome) | |||
Rev-bound HIV-1 mRNA | Arrow | R-HSA-165027 (Reactome) | ||
Rev-bound HIV-1 mRNA | R-HSA-165033 (Reactome) | |||
Rev-multimer | Arrow | R-HSA-165028 (Reactome) | ||
Rev-multimer | Arrow | R-HSA-180736 (Reactome) | ||
Rev-multimer | R-HSA-165033 (Reactome) | |||
Rev-multimer | R-HSA-180709 (Reactome) | |||
Rev:Importin-beta:B23 | Arrow | R-HSA-180732 (Reactome) | ||
Rev:Importin-beta:B23 | R-HSA-180728 (Reactome) | |||
Rev:Importin-beta:NPM1 | Arrow | R-HSA-180725 (Reactome) | ||
Rev:Importin-beta:NPM1 | R-HSA-180710 (Reactome) | |||
Rev:importin-beta:B23:Ran-GTP complex | Arrow | R-HSA-180728 (Reactome) | ||
Rev:importin-beta:B23:Ran-GTP complex | R-HSA-180736 (Reactome) | |||
SKP1 | R-HSA-180599 (Reactome) | |||
Tat (P04608) | R-HSA-167234 (Reactome) | |||
Tat:P-TEFb(Cyclin T1:Cdk9) complex | Arrow | R-HSA-167234 (Reactome) | ||
Ub | Arrow | R-HSA-180573 (Reactome) | ||
Ub | Arrow | R-HSA-180603 (Reactome) | ||
Ub | R-HSA-180540 (Reactome) | |||
Ub | R-HSA-180597 (Reactome) | |||
VIF (P69723) protein | R-HSA-180602 (Reactome) | |||
VPR | Arrow | R-HSA-180855 (Reactome) | ||
VPR | R-HSA-180855 (Reactome) | |||
VPR | R-HSA-180905 (Reactome) | |||
VPU (P05919) | R-HSA-180606 (Reactome) | |||
Vif:APOBEC3G complex | Arrow | R-HSA-180602 (Reactome) | ||
Vif:APOBEC3G complex | R-HSA-180555 (Reactome) | |||
Vif:APOBEC3G complex | TBar | R-HSA-180630 (Reactome) | ||
Vif:Cul5:SCF complex | Arrow | R-HSA-180603 (Reactome) | ||
Vpr:importin-alpha complex | Arrow | R-HSA-180627 (Reactome) | ||
Vpu:beta-TrCP1:Skp1 complex | Arrow | R-HSA-180573 (Reactome) | ||
XPO1 | Arrow | R-HSA-165028 (Reactome) | ||
XPO1 | R-HSA-180885 (Reactome) | |||
class I MHC complex | R-HSA-182243 (Reactome) | |||
multi-ubiquitinated APOBEC3G:Vif:Cul5:SCF complex | Arrow | R-HSA-180540 (Reactome) | ||
multi-ubiquitinated APOBEC3G:Vif:Cul5:SCF complex | R-HSA-180603 (Reactome) | |||
multiubiquitinated CD4:Vpu:beta-TrCP_1:Skp1 complex | Arrow | R-HSA-180597 (Reactome) | ||
multiubiquitinated CD4:Vpu:beta-TrCP_1:Skp1 complex | R-HSA-180573 (Reactome) | |||
myristoylated Nef
Protein (UniProt:P04601) | Arrow | R-HSA-167601 (Reactome) | ||
myristoylated Nef
Protein (UniProt:P04601) | Arrow | R-HSA-182171 (Reactome) | ||
myristoylated Nef
Protein (UniProt:P04601) | Arrow | R-HSA-182263 (Reactome) | ||
myristoylated Nef
Protein (UniProt:P04601) | R-HSA-164943 (Reactome) | |||
myristoylated Nef
Protein (UniProt:P04601) | R-HSA-167566 (Reactome) | |||
myristoylated Nef
Protein (UniProt:P04601) | R-HSA-167630 (Reactome) | |||
myristoylated Nef
Protein (UniProt:P04601) | R-HSA-182243 (Reactome) | |||
myristoylated Nef
Protein (UniProt:P04601) | R-HSA-200858 (Reactome) | |||
myristoylated Nef
Protein (UniProt:P04601) | R-HSA-200879 (Reactome) | |||
myristoylated Nef
Protein (UniProt:P04601) | R-HSA-200908 (Reactome) | |||
myristoylated Nef
Protein (UniProt:P04601) | R-HSA-200952 (Reactome) | |||
myristoylated Nef
Protein (UniProt:P04601) | R-HSA-200954 (Reactome) | |||
nucleoporin-associated Rev:Importin-beta:B23 complex | Arrow | R-HSA-180710 (Reactome) | ||
nucleoporin-associated Rev:Importin-beta:B23 complex | R-HSA-180732 (Reactome) |